Clominorex

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 15:07, 21 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Clominorex
Skeletal formula
Space-filling model of clominorex
Clinical data
ATC code
  • none
Identifiers
  • (RS)-5-(4-chlorophenyl)-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H9ClN2O
Molar mass196.63 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • Clc1ccc(cc1)C2O\C(=N/C2)N
  • InChI=1S/C9H9ClN2O/c10-7-3-1-6(2-4-7)8-5-12-9(11)13-8/h1-4,8H,5H2,(H2,11,12) checkY
  • Key:HAHOPPGVHWVBRR-UHFFFAOYSA-N checkY
  (verify)

Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]

See also

References

  1. ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same